Description
A 16-year-old girl with a medical history of tetralogy of Fallot repaired as an infant with right ventricle (RV) to pulmonary artery (PA) conduit presented to the emergency department with sudden onset fever of 38.4°C, leg cramps and poor oral intake. At admission, she was hypotensive and tachycardic. Blood cultures were positive for methicillin-sensitive Staphylococcus aureus with white blood cell count of 6.1 x10^9/L and C reactive protein 8.1. An echocardiogram found evidence for moderate conduit stenosis and severe right ventricular hypertrophy, without occlusive vegetation directly visualised. An initial chest CT angiogram (CTA) confirmed these findings, showing an incompletely occlusive vegetation in the RV to PA conduit and multiple peripheral and nodular ground glass opacities, some with cavitation, scattered throughout both lungs consistent with septic emboli (figure 1A). After initiation of anticoagulation and antibiotics, her clinical symptoms steadily improved. Repeat blood cultures remained negative. Follow-up chest CTA performed 4 weeks later demonstrated persistent conduit vegetation as well as new aneurysmal dilation of segmental pulmonary arteries in the regions of previously noted septic emboli, indicative of mycotic aneurysm formation ( figure 1B ). An echocardiogram performed on the same day showed evidence for haemodynamically significant conduit stenosis and persistently elevated right ventricular pressures. Surgical revision of the conduit was performed. A chest CTA 2 weeks following surgery demonstrated stability of the aneurysms. The immediate postoperative course was complicated by a pneumothorax and recurrent pleural effusions. After a short recovery, she was discharged home. Given her clinical improvement and overall stability of the aneurysms, it was determined that invasive therapeutic intervention carried greater risk than benefits. A conservative approach was pursued, and interval imaging was recommended to assess for stability.
Mycotic aneurysms are infections of the arterial wall that lead to weakening and dilation, resulting in outpouchings of the vessel. In those affecting the pulmonary arteries, Staphylococcus and Streptococcus are the usual culprits. There is a strong correlation between mycotic pulmonary artery aneurysms (MPAA) and congenital anomalies such as patent ductus arteriosus (PDA). Bartter et al hypothesised that the pathogenesis of MPAA in PDA is due to mechanical injury to the arterial wall from the PDA jet stream, leading to weakness and laying the groundwork for infectious involvement. 1 In our literature review (including years 1974-2017), we found only 18 cases of MPAAs in paediatric patients (excluding pseudoaneurysms), with 15 having history of congenital heart defects. Four individuals succumbed to aneurysmal rupture before treatment. Children with congenital cardiac abnormalities, particularly those treated with indwelling devices, are especially at risk. A high index of suspicion of MPAA should be maintained for patients with cardiac abnormalities that develop bacteraemia or septic emboli.
With such high incidence of rupture, aggressive intervention has been advocated though there is still a precedence for conservative management. 2 Of late, treatment has more commonly involved coil embolisation or stent placement, though removal of lung segments and aneurysmal resection have also been reported. Five of the 18 patients in our literature review were treated conservatively with two of the cases reporting aneurysmal regression. Kreibich et al recommended indications for surgery and advocated for conservative treatment in asymptomatic patients with no significant pulmonary artery hypertension and stability of aneurysmal diameter. 3 Imaging provides information that is often complementary to other diagnostic and clinical information, such as aneurysm size changes, which can directly influence the decision to treat. This highlights the importance of short interval imaging follow-up to monitor the size and status of the aneurysm and help guide clinical decision-making. provenance and peer review Not commissioned; externally peer reviewed.
